U.S. Mortgage Finance Stock News

Maximus (NYSE:MMS) amended its credit agreement to add $325 million to its existing term B loans. The company plans to use the new debt for share repurchases, working capital, and repayment of existing debt. Maximus, trading at $61.93, is taking on additional term B loan financing that directly affects how it allocates capital between shareholders and creditors. The move comes after the stock declined 28.4% year to date and 13.1% over the past year, with a 22.0% decline over three years and...

Wondering whether American Airlines Group at US$14.64 is a bargain or a value trap? This article walks through the key facts so you can judge the stock's price tag with more confidence. The stock has returned 5.7% over the last 7 days and 23.6% over the last 30 days. Year to date it is down 5.4%. The 5 year return shows a decline of 39.8%, with a 28.3% return over the last year and a 1.5% decline over 3 years. Recent coverage of American Airlines Group has focused on ongoing industry wide...

Western Digital (NasdaqGS:WDC) has introduced high-capacity hard drives that integrate post-quantum cryptography to secure AI-era data infrastructure. The new drives apply NIST-approved, quantum-resilient security standards directly in storage hardware to address long-term data protection risks. The launch targets enterprise and cloud environments where AI workloads generate sensitive, long-lived data sets. Western Digital is bringing this step into the spotlight at a time when its stock...

Wondering if VICI Properties at US$28.22 is a bargain or a trap? This article walks through what the current price might be implying about the stock's value. The share price is roughly flat year to date with a 0.2% gain, but has declined 1% over the last week and 1.3% over the past month, while the return over the last year is down 5.5%. Recent headlines around VICI Properties have focused on how the stock has trailed the broader Specialized REITs peer group over the last year, reinforcing...

HomesToLife (HTLM) has opened 2026 with Q1 revenue of US$92.5 million and basic EPS of US$0.04. Trailing twelve month revenue sits at US$390.9 million and EPS at US$0.19, framing a business that is currently earning at a higher run rate than any single recent quarter. The company has seen revenue move from US$335.1 million and EPS of US$0.09 on a trailing basis in Q4 2024 to US$390.9 million and EPS of US$0.19 by Q1 2026. This has occurred alongside a trailing net profit margin of 4.5% and...

World Health Organization recommends Regeneron’s maftivimab for priority evaluation in clinical trials for the current Bundibugyo ebolavirus outbreak. Maftivimab is a component of Inmazeb, which is already approved for Zaire ebolavirus treatment. The recommendation positions Regeneron Pharmaceuticals (NasdaqGS:REGN) within an active emergency response affecting multiple African countries. Regeneron Pharmaceuticals, traded as NasdaqGS:REGN, is widely known for its antibody platforms and...

United Fire Group (UFCS) is on investor watch after recent share price moves, with the stock down about 6% over the past week but up roughly 11% over the past month. See our latest analysis for United Fire Group. Zooming out from the latest pullback, United Fire Group’s share price has a 24.6% year to date gain and the 1 year total shareholder return of 59.1% points to strong recent momentum despite short term swings. If the insurance sector’s recent moves have your attention, this can be a...

Stifel Financial (NYSE:SF) reports strong growth in client assets and loans. Management links the progress to successful recruitment of financial advisors and rising venture banking activity. Recent operating results highlight higher fee-based client assets and treasury deposits alongside fund and venture banking loan growth. Stifel Financial, a diversified financial services company, is seeing fresh momentum in its core wealth and banking businesses as client assets, loans, and treasury...

In late May 2026, Safe Pro Group Inc. announced progress in its AI-powered threat detection collaboration with Lantronix, integrating Safe Pro’s algorithms into Lantronix’s Open-Q System-on-Module platform for real-time edge processing across drones and autonomous systems. This work, already tied to Qualcomm-based platforms and U.S. Army Short Range Reconnaissance drones under a Master Services Agreement, underscores Lantronix’s role in enabling NDAA-compliant, on-device AI for defense and...

QTREX Quantum Ltd., formerly Inspira Technologies Oxy B.H.N. Ltd., recently agreed to a US$10,000,000 private placement of 6,666,667 ordinary shares and earlier announced a US$580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems. Together with the upcoming ticker change to “QTEX” on the Nasdaq Capital Market, these moves highlight fresh institutional interest and early clinical adoption of the ART100 platform by a...

Securities class action lawsuit filed against Zoetis (NYSE:ZTS) and certain executives alleging misleading statements about product safety and demand in the Companion Animal division. Claims focus on disclosures around veterinarian adoption, competitive pressures, and demand trends for key Companion Animal products. The suit alleges that weakening prescriptions, new competition, and slowing demand were not fully communicated before guidance cuts. Zoetis, trading at $77.69, is facing this...

FDA has granted Priority Review for BridgeBio Pharma's BBP-418 for limb-girdle muscular dystrophy type 2I/R9. If approved, BBP-418 could become the first and only therapy for LGMD2I/R9 and the first treatment for any form of LGMD. The Priority Review follows acceptance of BridgeBio's NDA and is tied to plans for a near-term commercial launch. For investors following BridgeBio Pharma (NasdaqGS:BBIO), this regulatory step sits alongside a share price of $66.26, a 3-year return of around 4x,...

Humacyte recently reported research from its acellular tissue engineered vessel (ATEV) program showing long-term structural integrity and self-repair after years of repeated dialysis cannulation, alongside reduced infection susceptibility versus ePTFE grafts, and confirmed that top-line Phase 3 V012 dialysis access results are scheduled for release on June 11, 2026. Together with ongoing late-stage trials and an approved vascular trauma indication, the ATEV’s self-repair profile highlights...

Buckle (BKE) opened Q1 2027 with revenue of US$288.7 million and basic EPS of US$0.93, setting the tone against a trailing twelve month backdrop of US$1.3 billion in revenue and basic EPS of US$4.40. Over the past year, the company has seen quarterly revenue move from US$272.1 million in Q1 2026 to US$399.1 million in Q4 2026 before landing at US$288.7 million in the latest quarter, while basic EPS ranged from US$0.70 to US$1.60 over the same stretch, giving investors a clear read on how top...

Permian Basin Royalty Trust recently declared a reduced cash distribution of US$0.020355 per unit, payable on June 12, 2026, to unitholders of record on May 29, 2026. This lower payout highlights how shifts in royalty income can quickly affect income expectations for investors relying on the trust’s regular distributions. We’ll now examine how the reduced cash distribution shapes Permian Basin Royalty Trust’s investment narrative and what it may mean for income-focused holders. AI is about...

Willis Towers Watson (NasdaqGS:WTW) has announced new leadership appointments in its FINEX North America business to sharpen its cyber strategy. The moves include a new Head of Cyber and roles focused on executing cyber plans and deepening client engagement across North America. The changes come as AI driven risk, governance concerns, and cyber threats draw increased attention across the insurance and risk advisory sector. For investors following NasdaqGS:WTW, these appointments sit at the...

Earlier in May 2026, Netskope announced an integration between its Netskope One AI Security platform and Anthropic’s Claude Compliance API, enabling enterprises to apply unified visibility, policy enforcement, data protection, and compliance controls across their Claude Enterprise deployments in real time. This integration highlights how closely cloud security vendors and AI platform providers are now working together to embed governance directly into everyday AI workflows, reducing manual...

SentinelOne (S) just posted its Q1 2027 numbers, reporting revenue of US$276.7 million, a loss of US$76.2 million on a net income basis, and basic EPS of US$0.23 loss, with trailing twelve month revenue at about US$1.0 billion and a TTM net loss of US$318.7 million or EPS of US$0.96 loss. Over recent quarters the company has seen revenue move from US$229.0 million in Q1 2026 through US$271.2 million in Q4 2026 to US$276.7 million in Q1 2027. Quarterly basic EPS has ranged from a loss of...

Wondering whether Marriott International at around US$375.60 is still reasonable value after a strong run, or if you might be paying too much for the stock. The share price sits at US$375.60 after returns of 1.7% over the past week, 6.1% over the past month, 19.8% year to date and 43.6% over the last year. These moves naturally raise questions about growth potential and changing risk perceptions. Recent news coverage has focused on Marriott International's position as a large global hotel...

UiPath (PATH) has reported Q1 2027 revenue of US$418.4 million and basic EPS of US$0.04, setting a clear marker for how the automation specialist is currently converting top line into profit. The company has seen quarterly revenue move from US$356.6 million in Q1 2026 to US$418.4 million in Q1 2027, while basic EPS shifted from a loss of US$0.04 to a profit of US$0.04. This points to a materially different earnings profile compared with the same period last year. For investors, the key...

HealthEquity’s Q1 2027 earnings snapshot HealthEquity (HQY) opened its Q1 2027 report with total revenue of US$354.6 million and basic EPS of US$0.82, supported by net income of US$69.4 million. Over the past six quarters, revenue has moved from US$311.8 million in Q4 2025 to US$354.6 million in Q1 2027, while quarterly basic EPS has ranged from US$0.30 to US$0.82, and trailing twelve month EPS has reached US$2.70 on revenue of about US$1.3 billion. With trailing net profit margins reported...

If you are wondering whether Kennametal at around US$32.80 still offers value, the starting point is understanding what the current price already implies about the business. The stock is up 13.1% year to date and 56.7% over the past year, even though it has fallen 9.1% in the last week and 14.9% over the past month. This can change how investors view both its potential and its risks. Recent coverage has focused on how Kennametal fits into broader themes in capital goods and industrial...

In late May 2026, Robinhood Markets launched “Agentic Trading” and an “Agentic Credit Card,” letting customers connect third‑party AI agents to dedicated brokerage and virtual card accounts that can autonomously trade equities and make purchases within user‑defined limits and guardrails. The move effectively brings institutional‑style automated tools, such as portfolio construction, rebalancing and rule‑based strategies via platforms like ChatGPT and Claude, directly to retail investors,...

Investors may be considering whether Vertex Pharmaceuticals at around US$447.54 per share is offering good value right now, or if most of the opportunity is already reflected in the price. The stock has been relatively steady recently, with returns of 3.0% over the past week, 4.7% over the past month, a slight decline of 1.0% year to date, and a 1.2% return over the last year, alongside multi year figures of 34.1% over three years and 113.2% over five years. Recent headlines have focused on...